Kenneth A. Burdick's most recent trade in LifeStance Health Group Inc was a trade of 46,511 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on Aug. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Purchase of securities on an exchange or from another person at price $ 4.30 per share. | 08 Aug 2025 | 46,511 | 46,511 | - | 4.3 | 199,997 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Purchase of securities on an exchange or from another person at price $ 4.36 per share. | 08 Aug 2025 | 45,870 | 3,414,771 | - | 4.4 | 199,993 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Purchase of securities on an exchange or from another person at price $ 4.54 per share. | 08 Aug 2025 | 18,660 | 3,436,571 | - | 4.5 | 84,716 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 08 Aug 2025 | 1,800 | 3,416,571 | - | 4.3 | 7,758 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 08 Aug 2025 | 1,340 | 3,417,991 | - | 4.4 | 5,829 | Common Stock |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 556 | 367,052 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 3,579 | 366,496 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 500 | 362,917 (0%) | 0% | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.11 per share. | 10 Mar 2025 | 35,817 | 3,368,901 | - | 7.1 | 254,659 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 423,790 | 3,571,480 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 283,172 | 3,259,120 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 166,762 | 3,404,718 | - | 7.6 | 1,265,724 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 111,430 | 3,147,690 | - | 7.6 | 845,754 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 95,178 | 3,029,550 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 06 Mar 2025 | 53,602 | 2,975,948 | - | 7.9 | 422,384 | Common Stock |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 497 | 362,417 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 402 | 361,920 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 452 | 361,518 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 2,916 | 361,066 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 388 | 358,150 (0%) | 0% | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.28 per share. | 15 Mar 2024 | 214,605 | 2,934,372 | - | 6.3 | 1,347,719 | Common Stock |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 423,790 | 3,148,977 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 364,077 | 2,725,187 | - | 0 | Common Stock | |
| Centene | Burdick Kenneth A. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.07 per share. | 06 Feb 2024 | 33,066 | 357,762 (0%) | 0% | 74.1 | 2,449,199 | Common Stock |
| Centene | A. Kenneth Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 18,563 | 390,828 (0%) | 0% | 0 | Common Stock | |
| Centene | Burdick Kenneth A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 485 | 372,265 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 526 | 371,780 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 524 | 371,254 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 2,947 | 370,729 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 493 | 367,782 (0%) | 0% | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 1,816,239 | 1,816,239 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 544,871 | 2,361,110 | - | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.01 per share. | 07 Feb 2023 | 29,922 | 367,289 (0%) | 0% | 71.0 | 2,124,761 | Common Stock |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 1,901 | 397,211 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 428 | 395,310 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 366 | 394,881 (0%) | 0% | 0 | Common Stock | |
| LifeStance Health Group Inc | Kenneth A. Burdick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 9,404,539 | 9,404,539 | - | - | Stock Option (right to buy) | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 376 | 394,515 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corporation | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 6,385 | 44,253 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 2,323 | 394,139 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 82.02 per share. | 31 Mar 2022 | 381 | 391,816 (0%) | 0% | 82.0 | 31,250 | Common Stock |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 10,000 | 10,000 | - | - | Common Stock Option (right to buy) | |
| Centene | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 1,100 | 391,435 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | 21 Jan 2022 | 179,000 | 86,498 (0%) | 0% | 75 | 13,425,000 | Common Stock | |
| Centene | Kenneth A. Burdick | Director | 21 Jan 2022 | 1,790 | 0 | - | - | Common Stock Option (obligation to sell) | ||
| First Horizon Corporation | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 11,428 | 37,868 (0%) | 0% | 0 | Common Stock | |
| Centene | Kenneth A. Burdick | EVP, Markets & Products | Sale of securities on an exchange or to another person at price $ 70.16 per share. | 09 Nov 2020 | 35,000 | 803,386 (0%) | 0% | 70.2 | 2,455,600 | Common Stock |
| Centene | Kenneth A. Burdick | EVP, Markets & Products | Sale of securities on an exchange or to another person at price $ 62.02 per share. | 02 Nov 2020 | 35,000 | 838,386 (0%) | 0% | 62.0 | 2,170,700 | Common Stock |
| Centene | Kenneth A. Burdick | EVP, Markets & Products | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 05 Oct 2020 | 35,000 | 873,386 (0%) | 0% | 62 | 2,170,000 | Common Stock |